Lucid Diagnostics Inc.
LUCD
$1.39
$0.118.59%
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 20.08% | -2.50% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 20.08% | -2.50% | |||
| Cost of Revenue | 4.34% | -2.54% | |||
| Gross Profit | 19.75% | 2.60% | |||
| SG&A Expenses | 3.68% | 9.84% | |||
| Depreciation & Amortization | 0.00% | -32.26% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 5.74% | 3.18% | |||
| Operating Income | -4.49% | -3.71% | |||
| Income Before Tax | -12.41% | -3.70% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -12.41% | -3.70% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -12.41% | -3.70% | |||
| EBIT | -4.49% | -3.71% | |||
| EBITDA | -4.71% | -6.53% | |||
| EPS Basic | -7.58% | 43.25% | |||
| Normalized Basic EPS | -0.21% | 3.55% | |||
| EPS Diluted | -7.58% | 43.25% | |||
| Normalized Diluted EPS | -0.21% | 3.55% | |||
| Average Basic Shares Outstanding | 4.48% | 7.10% | |||
| Average Diluted Shares Outstanding | 4.48% | 7.10% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
